772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?C. Van Praet,Sylvie Rottey, F. Van Hende,Gino Pelgrims,Wim Demey,F. Van Aelst,Wim Wynendaele,Thierry Gil,P. Schatteman,Bertrand Filleul,D. Schallier,J-P Machiels,Dirk Schrijvers,Els Everaert,Linda Dhondt,Patrick Werbrouck,Joanna Vermeij,Jeroen Mebis,Marylene Clausse,Marika Rasschaert, J. Van Erps,Jolanda Verheezen, J. Van Haverbeke,J-C. Goeminne,Nicolaas LumenEuropean Urology Supplements（2016）引用 0|浏览34暂无评分关键词Metastatic Prostate CancerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
